My Top 10 Favorite Quotes of 2025
A look back at some of the most intriguing statements from Healthcare Innovation interviews in the past year
2025
Read More
Journalists Zero In on ‘Certificate of Need’ Laws and Turbulent Obamacare Enrollment Season
KFF Health News senior correspondent Renuka Rayasam discussed gun violence in Bogalusa, Louisiana, on KALW’s Your Call on Dec. 19. Click here to hear Rayasam on Your Call. Read Rayasam’s “Guns, Race, and Profit: The Pain of America’s Other Epidemic,” co-reported with Fred Clasen-Kelly. KFF Health News rural health correspondent Andrew Jones discussed the implications…
Key Data on Health and Health Care for American Indian or Alaska Native People
AIAN individuals experience significant health disparities compared to their White counterparts. People who identified as AIAN alone have shorter life expectancies (70.1 vs 78.4 years at birth), higher rates of chronic diseases, and higher rates of suicide deaths and substance use disorder.
Health and Health Care for American Indian or Alaska Native People: Key Issues
Due to a combination of lower coverage rates, additional access barriers, and historical and ongoing discrimination, AIAN people continue to face significant disparities in health and health care.
How Kaiser Permanente Consolidated 12 EHRs into 2
Kaiser Permanente consolidated 12 EHR instances across California into two in a matter of hours without disrupting patient care. This project has simplified clinical workflows and improved data consistency, as well as provided a rare example of EHR consolidation executed successfully at scale, said Neil Cowles, the health system’s chief information and technology officer. The…
BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition
BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics is a marriage of two rare disease biotech companies. Amicus’s two commercialized products, for the enzyme deficiencies Fabry disease and Pompe disease, are each projected to become blockbuster sellers. The post BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition appeared first on MedCity News.
State Exchange Directors Seeing Consumers’ Fears — In Real Time — About Obamacare Premium Hikes
I’ve been checking on the progress of the Affordable Care Act’s open enrollment season, which is happening as Congress continues to debate whether to extend the subsidies that have given consumers extra help paying their health insurance premiums. The story drew responses from readers facing large cost increases if these enhanced subsidies expire. They wrote…
Codoxo Raises $35M to Prevent Healthcare Payment Errors
Codoxo’s funding was led by CVS Health Ventures and included participation from Echo Health Ventures, Sands Capital and 111 West Capital. The post Codoxo Raises $35M to Prevent Healthcare Payment Errors appeared first on MedCity News.
CMS’ LEAD Model Seeks to Address ACO REACH’s Limitations
ACO model includes 10-year pathway toward sustainable benchmarks and capitated population-based payments to support team-based care
Bringing Joy Back to Healthcare: The Power of Accountable Partnerships
Healthcare organizations must orient their models around outcomes rather than technology and capabilities alone — and that can be done through novel accountable partnerships built on a care enablement platform. The post Bringing Joy Back to Healthcare: The Power of Accountable Partnerships appeared first on MedCity News.